ACE inhibitors reduced cardiovascular events and all-cause mortality in elderly persons with hypertension

Davidson, Richard
September 2003
ACP Journal Club;Sep/Oct2003, Vol. 139 Issue 2, p38
Academic Journal
Presents a study that compared the effectiveness of angiotensin-converting enzyme inhibitors with a therapy based on diuretics, in reducing cardiovascular events and all-cause mortality in older persons with hypertension. Design; Intervention; Outcome measures; Results; Commentary.


Related Articles

  • Body-mass index: For older adults, bigger is sometimes better.  // Modern Medicine;Jun98, Vol. 66 Issue 6, p9 

    Presents an abstract of the article Body Mass Index and Mortality in Nonsmoking Older Adults: The Cardiovascular Health Study,' by P. Diehr, D.E. Bild, et al from the `American Journal of Public Health' dated April 1998.

  • Omega-3 Fatty Acid Supplementation Does Not Decrease CVD-Related Outcomes. SHAUGHNESSY, ALLEN F. // American Family Physician;11/1/2014, Vol. 90 Issue 9, p662 

    The article discusses research on the effectiveness of omega-3 fatty acid in decreasing cardiovascular disease (CVD)-related outcomes in older patients with macular degeneration. It references the study "Effect of Long-Term Chain Omega-3 Fatty Acids and Lutein + Zeaxanthin Supplements on...

  • Aspirin and cognitive function. Whalley, Lawrence J.; Mowat, Donald H.R. // BMJ: British Medical Journal (International Edition);5/12/2007, Vol. 334 Issue 7601, p961 

    This article presents an editorial on the use of aspirin to maintain cognitive function in older persons. The author says while the benefit of aspirin therapy on cognitive function may not have been proven yet, it may be due to difficulties in selecting the right outcome measures. Many studies...

  • Antioxidant Products: Nutritional Science and Marketplace Opportunities. Archibald, Amanda // Prepared Foods;May2007 Supplement, Vol. 176, p2 

    The article focuses on the benefits of antioxidants to human health. It states that baby boomers attribute their ability to reduce the risk of cardiovascular incidents and other diseases to antioxidants. To prevent oxidative damage due to reactive oxygen species is said to be the goal of...

  • one.  // Prevention;Apr2014, Vol. 66 Issue 4, p22 

    The article offers information related to a study published in study in the British Medical Journal that suggests adults over 50 year of age taking a piece of fruit helps in reducing the risk of cardiovascular diseases and stroke.

  • Vitamins E and C in the Prevention of Cardiovascular Disease in Men. Sesso, Howard D.; Buring, Julie E.; Christen, William G.; Kurth, Tobias; Belanger, Charlene; MacFadyen, Jean; Bubes, Vadim; Manson, JoAnn E.; Glynn, Robert J.; Gaziano, J. Michael // JAMA: Journal of the American Medical Association;11/12/2008, Vol. 300 Issue 18, p2123 

    The article reports on the results of research which was conducted in an effort to evaluate whether long term vitamin E or vitamin C supplementation decreases the risk of many cardiovascular events and diseases in older men. Researchers used a randomized, double blind, placebo controlled study...

  • Direct Renin Inhibition: A New Option for End-Organ Protection.  // MD Conference Express;Oct2010, p28 

    The article discusses the options for blocking renin-angiotensin-aldosterone system (RAAS) to prevent organ damage in patients with elevated cardiovascular (CV) risk presented by Matthew R. Weir during the 25th Annual Caribbean Cardiology Conference. It says that the effective blood pressure...

  • RAAS inhibition/blockade in patients with cardiovascular disease: implications of recent large-scale randomised trials for clinical practice. Pitt, Bertram // Heart;Aug2009, Vol. 95 Issue 15, p1 

    The article discusses the findings of the study ONTARGET and TRANSCEND which examines the efficacy of renin-angiotensin-aldosterone system (RAAS) inhibition and blockade to reduce the mortality and morbidity rate of cardiovascular diseases in the U.S. It notes that the effectiveness of...

  • Prescription Data Related to the Use of Calcium Channel Blockers, ACE Inhibitors and Angiotensin II Type 1 Receptor Antagonists (Angiotensin Receptor Blockers) in Combination Identify Savings Opportunities. Carugo, Stefano; Rossetti, Giuseppe; Merlino, Luca; Mancia, Giuseppe // High Blood Pressure & Cardiovascular Prevention;Mar2009, Vol. 16 Issue 1, p21 

    Background: It is now recognized that treating hypertension with combination therapy is required to achieve target blood pressure in the majority of patients. Objective: To investigate the use of ACE inhibitors, angiotensin II type 1 receptor antagonists (angiotensin receptor blockers [ARBs])...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics